The Urokinase Receptor in Hematopoietic Stem Cells Mobilization

被引：3

作者：

Blasi, Francesco ^{[1
,2
]}

机构：

[1] Ist Sci San Raffaele, I-20132 Milan, Italy

[2] IFOM FIRC Inst Mol Oncol, I-20136 Milan, Italy

来源：

CURRENT PHARMACEUTICAL DESIGN | 2011年 / 17卷 / 19期

关键词：

Urokinase receptor; hematopoietic stem cells; mobilization; plasminogen activation; PLASMINOGEN-ACTIVATOR RECEPTOR; IN-VIVO; OBSTRUCTIVE NEPHROPATHY; HUMAN CARCINOMA; LINKER REGION; MIGRATION; UPAR; VITRONECTIN; COMPLEX; RECRUITMENT;

D O I：

10.2174/138161211796718206

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The receptor for urokinase plasminogen activator (uPAR) is required in hematopoietic stem/progenitor cells (HSC, HPC) mobilization in the mouse. Indeed, uPAR Ko mice are deficient both in retention and mobilization of HSC and HPC, because uPAR causes their retention in the BM through its interaction with the 4 1 integrin and at the same time its removal promotes their migration. Normally, the membrane signal is cleaved by plasmin which on one side releases the cells from their osteoblasts interaction and on the other produces a cleaved soluble uPAR product that stimulates mobilization. Available data suggest that a similar mechanism may take place in humans.

引用

页码：1911 / 1913

页数：3

共 32 条

[1]

Andolfo A, 2002, THROMB HAEMOSTASIS, V88, P298

[2] Structural basis of interaction between urokinase-type plasminogen activator and its receptor [J].

Barinka, Cyril ;

Parry, Graham ;

Callahan, Jennifer ;

Shaw, David E. ;

Kuo, Alice ;

Bdeir, Khalil ;

Cines, Douglas B. ;

Mazar, Andrew ;

Lubkowski, Jacek .

JOURNAL OF MOLECULAR BIOLOGY, 2006, 363 (02) :482-495

[3] Plasmin cleaves the juxtamembrane domain and releases truncated species of the urokinase receptor (CD87) from human bronchial epithelial cells [J].

Beaufort, N ;

Leduc, D ;

Rousselle, JC ;

Namane, A ;

Chignard, M ;

Pidard, D .

FEBS LETTERS, 2004, 574 (1-3) :89-94

[4] uPAR: A versatile signalling orchestrator [J].

Blasi, F ;

Carmeliet, P .

NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (12) :932-943

[5] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - PROENZYME, RECEPTOR, AND INHIBITORS [J].

BLASI, F ;

VASSALLI, JD ;

DANO, K .

JOURNAL OF CELL BIOLOGY, 1987, 104 (04) :801-804

[6] UROKINASE PLASMINOGEN-ACTIVATOR RECEPTOR, BETA-2-INTEGRINS, AND SRC-KINASES WITHIN A SINGLE RECEPTOR COMPLEX OF HUMAN MONOCYTES [J].

BOHUSLAV, J ;

HOREJSI, V ;

HANSMANN, C ;

STOCKL, J ;

WEIDLE, UH ;

MAJDIC, O ;

BARTKE, I ;

KNAPP, W ;

STOCKINGER, H .

JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (04) :1381-1390

[7] uPAR-deficient mouse keratinocytes fail to produce EGFR-dependent laminin-5, affecting migration in vivo and in vitro [J].

D'Alessio, Silvia ;

Gerasi, Laura ;

Blasi, Francesco .

JOURNAL OF CELL SCIENCE, 2008, 121 (23) :3922-3932

[8] Urokinase induces basophil chemotaxis through a urokinase receptor or epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2 [J].

de Paulis, A ;

Montuori, N ;

Prevete, N ;

Fiorentino, I ;

Rossi, FW ;

Visconte, V ;

Rossi, G ;

Marone, G ;

Ragno, P .

JOURNAL OF IMMUNOLOGY, 2004, 173 (09) :5739-5748

[9]

Furlan F, 2007, J BONE MIN IN PRESS

[10] Mapping of the vitronectin-binding site on the urokinase receptor -: Involvement of a coherent receptor interface consisting of residues from both domain I and the flanking interdomain linker region [J].

Gardsvoll, Henrik ;

Ploug, Michael .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (18) :13561-13572

← 1 2 3 4 →